HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Antoine Blancher Selected Research
Antoine Blancher Research Topics
Disease
3
HIV Infections (HIV Infection)
02/2006 - 03/2005
2
Infections
01/2020 - 08/2003
2
Vasculitis (Vasculitides)
01/2020 - 08/2015
2
Disease Progression
02/2006 - 08/2003
2
Acquired Immunodeficiency Syndrome (AIDS)
02/2006 - 08/2003
1
Bites and Stings (Sting)
06/2022
1
Virus Diseases (Viral Diseases)
06/2022
1
COVID-19
01/2022
1
Systemic Scleroderma (Systemic Sclerosis)
01/2021
1
Giant Cell Arteritis (Horton Disease)
01/2020
1
Tuberculosis (Tuberculoses)
01/2020
1
Latent Tuberculosis
01/2020
1
Systemic Vasculitis
01/2020
1
Inflammation (Inflammations)
01/2019
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1
Atypical Hemolytic Uremic Syndrome
10/2017
1
Multiple Sclerosis
07/2016
1
Cryofibrinogenemia
08/2015
1
Colorectal Neoplasms (Colorectal Cancer)
06/2015
1
Hematologic Neoplasms (Hematological Malignancy)
08/2014
1
Lymphopenia (Lymphocytopenia)
08/2014
1
Communicable Diseases (Infectious Diseases)
08/2012
1
Immune Reconstitution Inflammatory Syndrome
04/2011
1
Pneumocystis Infections
12/2010
1
Hepatitis B
09/2008
1
Cryoglobulinemia
09/2008
Drug/Important Bio-Agent (IBA)
2
Cytokines
IBA
06/2022 - 12/2010
2
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2020 - 08/2015
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020 - 08/2015
2
Chemokine CCL5
IBA
02/2006 - 08/2003
2
Chemokines
IBA
02/2006 - 08/2003
2
Chemokine Receptors
IBA
02/2006 - 08/2003
1
cyclic guanosine monophosphate-adenosine monophosphate
IBA
06/2022
1
Toll-Like Receptor 7
IBA
06/2022
1
resiquimod
IBA
06/2022
1
ODN M362
IBA
06/2022
1
Interferon Type I
IBA
06/2022
1
Complement System Proteins (Complement)
IBA
01/2022
1
Autoantibodies
IBA
01/2021
1
Biological Products
IBA
01/2020
1
Antiviral Agents (Antivirals)
IBA
01/2020
1
Gold
IBA
01/2020
1
Cytidine Triphosphate (CTP)
IBA
01/2019
1
eculizumab
FDA Link
10/2017
1
Immunoglobulin G (IgG)
IBA
07/2016
1
cryofibrinogen
IBA
08/2015
1
CD100 antigen
IBA
06/2015
1
alpha Catenin (alpha E-Catenin)
IBA
06/2015
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2015
1
Caspase 9
IBA
06/2015
1
HLA-DR Antigens (HLA-DR)
IBA
08/2014
1
Vaccines
IBA
08/2012
1
Complement C4 (Complement Component 4)
IBA
09/2008
1
Alanine Transaminase (SGPT)
IBA
09/2008
1
Complement C3 (C3 Complement)
IBA
09/2008
1
Antibodies
IBA
09/2008
1
Antinuclear Antibodies
IBA
09/2008
1
Chemokine CXCL12
IBA
02/2006
1
CX3C Chemokine Receptor 1
IBA
02/2006
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
08/2005
1
Antigens
IBA
03/2005
1
Glycosyltransferases
IBA
03/2005
1
DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)
IBA
03/2005
1
Lewis Blood Group Antigens
IBA
03/2005
1
Fucosyltransferases
IBA
03/2005
1
AIDS Vaccines
IBA
08/2003
Therapy/Procedure
3
Therapeutics
01/2020 - 08/2003
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019
1
Plasmapheresis
08/2015
1
Hematopoietic Stem Cell Transplantation
08/2014
1
Liver Transplantation
09/2008
1
Highly Active Antiretroviral Therapy (HAART)
02/2006